✦ LIBER ✦

Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations

✍ Scribed by Wendy R Galpern; Jacqueline Corrigan-Curay; Anthony E Lang; Jeffrey Kahn; Danilo Tagle; Roger A Barker; Thomas B Freeman; Christopher G Goetz; Karl Kieburtz; Scott YH Kim; Steven Piantadosi; Amy Comstock Rick; Howard J Federoff

Book ID: 117792153
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 95 KB
Volume: 11
Category: Article
ISSN: 1474-4465
DOI: 10.1016/s1474-4422(12)70064-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biomarkers in clinical trials for neurod

Biomarkers in clinical trials for neurodegenerative diseases: Regulatory perspectives and requirements

✍ Karl Broich; Marco Weiergräber; Harald Hampel 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Lay conceptions of the ethical and scien

Lay conceptions of the ethical and scientific justifications for random allocation in clinical trials

✍ Elizabeth J Robinson; Cicely Kerr; Andrew Stevens; Richard Lilford; David Braunh 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Ethical considerations in the design of

Ethical considerations in the design of a randomized clinical trial of nutritional therapy for chronic renal disease

✍ Anna M. Sanberg; George W. Williams; Andrew S. Levey 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Scientific and Ethical Issues in the Use

Scientific and Ethical Issues in the Use of Placebo and Active Controls in Clinical Trials

✍ Susan S Ellenberg 📂 Article 📅 2003 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 31 KB

Considerations in the design of a large-

Considerations in the design of a large-scale clinical trial of short-course preventive therapy for tuberculosis: Lawrence J. Geiter and George M. Cauthen Centers for Disease Control, Division of Tuberculosis Control, Atlanta, Georgia(60)

📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Monitoring the worker for exposure and d

Monitoring the worker for exposure and disease: Scientific, legal, and ethical considerations in the use of biomarkers, by Nicholas A. Ashford, Dale B. Hattis, Christine J. Spadafor and Charles C. Caldart, Johns Hopkins University Press, Baltimore, MD, 1990. 224 pages, $19.95

✍ Mr. Sheldon W. Samuels 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

While biomarkers are hardly new phenomena, recent advances in molecular biology combined with widespread computerization of data bases now make biomarked personal data with genetic import potentially accessible on a massive scale. While limited in predictive value at this time, the data can be easil